Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on December 12, 2002

Stroke. 2002
Published online before print December 12, 2002, doi: 10.1161/01.STR.0000048162.16852.88
A more recent version of this article appeared on January 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/1/203    most recent
01.STR.0000048162.16852.88v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dong, Y.
Right arrow Articles by Markus, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dong, Y.
Right arrow Articles by Markus, H. S.
Related Collections
Right arrow Cerebral Lacunes
Right arrow Genetics of Stroke
Right arrow Other Stroke

Submitted on August 8, 2002
Accepted on August 13, 2002

Yield of Screening for CADASIL Mutations in Lacunar Stroke and Leukoaraiosis

Yanbin Dong PhD; Ahamad Hassan MRCP*; Zhongyi Zhang MSc; Dionne Huber MSc; Chrysoula Dalageorgou BSc; and Hugh S. Markus FRCP

From the Department of Clinical Neurosciences, St George's Hospital Medical School, London, United Kingdom.

* To whom correspondence should be addressed. E-mail: a.hassan{at}sghms.ac.uk.

Background and Purpose—Cerebral autosomal dominant arteriopathy subcortical infarcts and leukoencephalopathy (CADASIL) is a monogenic disorder typified by early onset lacunar strokes, subcortical dementia, psychiatric disturbances, and migraine. Mutations in the Notch3 gene are responsible. Atypical phenotypes have been recognized, and the disease is probably underdiagnosed in the wider stroke population. Therefore, we determined the yield of screening for Notch3 mutations in lacunar stroke with or without leukoaraiosis.

Methods—Two hundred eighteen consecutive patients were studied. All had brain and carotid imaging. Polymerase chain reaction-single-stranded conformational polymorphism analysis was used to screen exons 3, 4, 5, and 6 of the Notch3 gene for mutations and polymorphisms.

Results—A single mutation in exon 4 (C697T) was identified in a young patient, giving an overall carrier frequency of 0.05% (95% CI, 0.0 to 2.0). For patients with onset of lacunar stroke at <=65 years and leukoaraiosis, the yield was 2.0% (95% CI, 0.4 to 10.9).

ConclusionsNotch3 mutations are rare in patients with typical strokes due to cerebral small-vessel disease. In the absence of classic features suggestive of CADASIL, screening for Notch3 mutations has a low yield.


Key words: CADASIL • genetic screening • lacunar infarction • leukoaraiosis




This article has been cited by other articles:


Home page
NeurologyHome page
M. Liguori, R. Mazzei, C. Ungaro, I. L. Simone, A. Gambardella, I. Plasmati, F. Fera, U. Aguglia, P. Lanza, F. Bono, et al.
CONVENTIONAL MRI AND NOTCH3 GENE SCREENING IN SPORADIC CADASIL
Neurology, February 3, 2009; 72(5): 469 - 471.
[Full Text] [PDF]


Home page
CirculationHome page
M. D. Napoli and F. Papa
C-Reactive Protein and Cerebral Small-Vessel Disease: An Opportunity to Reassess Small-Vessel Disease Physiopathology?
Circulation, August 9, 2005; 112(6): 781 - 785.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H Markus
Genes for stroke
J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1229 - 1231.
[Full Text] [PDF]


Home page
CMAJHome page
J. E. Simon, J. Parboosingh, A. Clark, D. George, A.-L. Lafontaine, and M. D. Hill
A 52-year-old man with cognitive decline, seizure and stroke
Can. Med. Assoc. J., April 27, 2004; 170(9): 1393 - 1394.
[Full Text] [PDF]


Home page
StrokeHome page
M. J. Alberts
Genetics of Cerebrovascular Disease
Stroke, February 1, 2004; 35(2): 342 - 344.
[Full Text] [PDF]